Developed in partnership with the Our Partner
In "Beyond Diagnosis: Multiple Myeloma," Cleveland Clinic hematologist Sandra Mazzoni, DO, and host John Mangels continue their conversations on communicating effectively and empathetically with patients facing a complex, chronic blood cancer.
Each monthly installment examines an aspect of multiple myeloma care, including delivering the diagnosis, aligning treatment goals, navigating evolving therapies, and supporting patients through an increasingly personalized treatment landscape.
This third of six episodes focuses on discussing emerging cell therapies, explaining transplant decisions, and helping patients weigh complex treatment options in the context of their personal priorities and long-term goals.
The following is a transcript of their remarks:
